He-San Luo Selected Research

Squamous Cell Neoplasms (Squamous Cell Cancer)

10/2021	Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
10/2020	A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
1/2020	Prognostic Significance of Baseline Neutrophil Count and Lactate Dehydrogenase Level in Patients With Esophageal Squamous Cell Cancer Treated With Radiotherapy.
10/2019	Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis.
5/2019	Impact of sex on the prognosis of patients with esophageal squamous cell cancer underwent definitive radiotherapy: a propensity score-matched analysis.
3/2019	Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
1/2019	Preoperative Administration of Olive Oil Reduces Chylothorax After Minimally Invasive Esophagectomy.
12/2017	Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

He-San Luo Research Topics

Disease

8	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2021 - 12/2017
4	Esophageal Squamous Cell Carcinoma 10/2021 - 12/2017
4	Neoplasms (Cancer) 01/2020 - 04/2011
2	Esophageal Neoplasms (Esophageal Cancer) 10/2019 - 10/2018
1	Triple Negative Breast Neoplasms 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Carcinogenesis 03/2019
1	Chylothorax 01/2019
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Adenoma (Adenomas) 04/2011
1	Colorectal Neoplasms (Colorectal Cancer) 04/2011
1	Lymphatic Metastasis 04/2011

Drug/Important Bio-Agent (IBA)

1	taxaneIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	AnthracyclinesIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 03/2019
1	MicroRNAs (MicroRNA)IBA 03/2019
1	Olive OilIBA 01/2019
1	Casein Kinases (Casein Kinase)IBA 04/2011
1	Proteins (Proteins, Gene)FDA Link 04/2011
1	Small Interfering RNA (siRNA)IBA 04/2011

Therapy/Procedure

5	Radiotherapy 10/2021 - 10/2018
2	Chemoradiotherapy 10/2020 - 12/2017
2	Therapeutics 01/2020 - 01/2019
2	Consolidation Chemotherapy 10/2018 - 12/2017
1	Neoadjuvant Therapy 01/2021
1	Immunotherapy 01/2020
1	Esophagectomy 01/2019